Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Csaba Szabo

Showing results (221-230 of 249) with videos related to

Pageof 25
Sort By:
Molecular Cancer Therapeutics|September 20, 2005
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograftC Lynn Cheng, Stewart P Johnson, Stephen T Keir, et al.
Critical Care Medicine|December 4, 2008
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injuryPerenlei Enkhbaatar, Rhykka Connelly, Jianpu Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated <i>Caenorhabditis elegans</i>Adriana Raluca Vintila, Luke Slade, Michael Cooke, et al.
Hepatology (Baltimore, Md.)|October 4, 2013
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosisPartha Mukhopadhyay, Mohanraj Rajesh, Zongxian Cao, et al.
Biomolecules|August 27, 2021
Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition ConceptMark R Hellmich, Celia Chao, Katalin Módis, et al.
Biochemical Pharmacology|April 7, 2009
Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genesJana Reinemund, Kerstin Seidel, Ulrike M Steckelings, et al.
Molecular Medicine (Cambridge, Mass.)|September 9, 2015
The HIV Protease Inhibitor Saquinavir Inhibits HMGB1-Driven Inflammation by Targeting the Interaction of Cathepsin V with TLR4/MyD88John P Pribis, Yousef Al-Abed, Huan Yang, et al.
Molecular Medicine (Cambridge, Mass.)|August 8, 2013
Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensisTonyia Eaves-Pyles, Jignesh Patel, Emma Arigi, et al.
Pharmacological Research|August 14, 2016
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancerNadiya Druzhyna, Bartosz Szczesny, Gabor Olah, et al.
Geroscience|July 9, 2024
Phylloquinone improves endothelial function, inhibits cellular senescence, and vascular inflammationAnna Kieronska-Rudek, Agnieszka Kij, Anna Bar, et al.
Pageof 25

Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
Molecular Cancer Therapeutics|September 20, 2005
Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograftC Lynn Cheng, Stewart P Johnson, Stephen T Keir, et al.
Critical Care Medicine|December 4, 2008
Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injuryPerenlei Enkhbaatar, Rhykka Connelly, Jianpu Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2023
Mitochondrial sulfide promotes life span and health span through distinct mechanisms in developing versus adult treated <i>Caenorhabditis elegans</i>Adriana Raluca Vintila, Luke Slade, Michael Cooke, et al.
Hepatology (Baltimore, Md.)|October 4, 2013
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosisPartha Mukhopadhyay, Mohanraj Rajesh, Zongxian Cao, et al.
Biomolecules|August 27, 2021
Efficacy of Novel Aminooxyacetic Acid Prodrugs in Colon Cancer Models: Towards Clinical Translation of the Cystathionine β-Synthase Inhibition ConceptMark R Hellmich, Celia Chao, Katalin Módis, et al.
Biochemical Pharmacology|April 7, 2009
Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genesJana Reinemund, Kerstin Seidel, Ulrike M Steckelings, et al.
Molecular Medicine (Cambridge, Mass.)|September 9, 2015
The HIV Protease Inhibitor Saquinavir Inhibits HMGB1-Driven Inflammation by Targeting the Interaction of Cathepsin V with TLR4/MyD88John P Pribis, Yousef Al-Abed, Huan Yang, et al.
Molecular Medicine (Cambridge, Mass.)|August 8, 2013
Immunomodulatory and antibacterial effects of cystatin 9 against Francisella tularensisTonyia Eaves-Pyles, Jignesh Patel, Emma Arigi, et al.
Pharmacological Research|August 14, 2016
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancerNadiya Druzhyna, Bartosz Szczesny, Gabor Olah, et al.
Geroscience|July 9, 2024
Phylloquinone improves endothelial function, inhibits cellular senescence, and vascular inflammationAnna Kieronska-Rudek, Agnieszka Kij, Anna Bar, et al.
Pageof 25